|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Healthy | |||||
| Lung Disease | |||||
| Sepsis | |||||
| Septic Shock | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Lung Diseases | |||||
| Shock, Septic | |||||
| 3 | More general conditions related to this trial | ||||
| Infection | |||||
| Inflammation | |||||
| Pathologic Processes | |||||
| Respiratory Tract Diseases | |||||
| Shock | |||||
| Systemic Inflammatory Response Syndrome | |||||
| 4 | Interventions listed in this trial | ||||
| Reference Endotoxin | |||||
| Inhaled Nitric Oxide | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Nitric Oxide | |||||
| 6 | More general drug interventions related to this trial | ||||
| Anti-Asthmatic Agents | |||||
| Antioxidants | |||||
| Autonomic Agents | |||||
| Bronchodilator Agents | |||||
| Cardiovascular Agents | |||||
| Endothelium-Dependent Relaxing Factors | |||||
| Free Radical Scavengers | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| Respiratory System Agents | |||||
| Therapeutic Uses | |||||
| Vasodilator Agents | |||||
| 7 | Sponsors listed in this trial | ||||
| National Institutes of Health Clinical Center (CC) | |||||